October 26

Congressional Hearing: What did drug companies & FDA hide?

Congressional Hearing: What did drug companies & FDA hide?

Fri, 16 Jul 2004

AHRP has learned that the Congressional hearing by the House Subcommittee on Oversight and Investigations, scheduled for Tuesday, July 20, 2004 at 9:30 AM, will have a line up of major pharmaceutical industry executives who will be questioned about their companies’ failure to disclose clinical trial test results from antidepressant trials conducted in children / adolescents.

Two other panels of top officials of the American Academy of Pediatrics, the American Medical Association and the FDA are also scheduled. The hearing is scheduled for the full day.

The media is advised not to miss the opportunity of hearing major drug company executives testify under oath what they knew about the safety of antidepressants and what they withheld.

The FDA will have to explain the agency’s failure to ensure that physicians and the public were warned about evidence of an increased risk of suicide in children prescribed an antidepressant, and the failure of antidepressants to demonstrate a benefit for children in clinical trials.

Contact: Vera Hassner Sharav
Tel: 212-595-8974

Update: Cong hearing on July 20 is postponed until September


Subscribe To Our Newsletter!

Sign up and be the first to find out the latest news and articles about what's going on in the medical field.


You may also like

January 26, 2023

The last generation of Holocaust survivors and their children express their concerns about current events A Five-Part

Read More
Vera Sharav’s documentary “Never Again is Now Global” now available

October 26, 2022

FDA Advisory Panel & CDC Director are Complicit in Sacrificing Children’s Lives to Protect Pfizer from Liability 

Read More
FDA Advisory Panel & CDC Director are Complicit in Sacrificing Children’s Lives to Protect Pfizer from Liability